These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21159649)

  • 1. Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas.
    Rothbart SB; Racanelli AC; Moran RG
    Cancer Res; 2010 Dec; 70(24):10299-309. PubMed ID: 21159649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.
    Racanelli AC; Rothbart SB; Heyer CL; Moran RG
    Cancer Res; 2009 Jul; 69(13):5467-74. PubMed ID: 19549896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells.
    Agarwal S; Bell CM; Rothbart SB; Moran RG
    J Biol Chem; 2015 Nov; 290(46):27473-86. PubMed ID: 26391395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
    Chen MB; Shen WX; Yang Y; Wu XY; Gu JH; Lu PH
    J Cell Physiol; 2011 Jul; 226(7):1915-25. PubMed ID: 21506122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition.
    Zhang WB; Wang Z; Shu F; Jin YH; Liu HY; Wang QJ; Yang Y
    J Biol Chem; 2010 Dec; 285(52):40461-71. PubMed ID: 20880848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic control of muscle cell size by AMPK and mTORC1.
    Mounier R; Lantier L; Leclerc J; Sotiropoulos A; Foretz M; Viollet B
    Cell Cycle; 2011 Aug; 10(16):2640-6. PubMed ID: 21799304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy.
    Huang H; Kang R; Wang J; Luo G; Yang W; Zhao Z
    Autophagy; 2013 Feb; 9(2):175-95. PubMed ID: 23169238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes.
    Campàs C; Lopez JM; Santidrián AF; Barragán M; Bellosillo B; Colomer D; Gil J
    Blood; 2003 May; 101(9):3674-80. PubMed ID: 12522004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells.
    Li H; Thali RF; Smolak C; Gong F; Alzamora R; Wallimann T; Scholz R; Pastor-Soler NM; Neumann D; Hallows KR
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F167-77. PubMed ID: 20462973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferating effect of orotic acid through mTORC1 activation mediated by negative regulation of AMPK in SK-Hep1 hepatocellular carcinoma cells.
    Jung EJ; Lee KY; Lee BH
    J Toxicol Sci; 2012; 37(4):813-21. PubMed ID: 22863860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
    Thomson DM; Fick CA; Gordon SE
    J Appl Physiol (1985); 2008 Mar; 104(3):625-32. PubMed ID: 18187610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte.
    Chan AY; Soltys CL; Young ME; Proud CG; Dyck JR
    J Biol Chem; 2004 Jul; 279(31):32771-9. PubMed ID: 15159410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic regulation of neuronal plasticity by the energy sensor AMPK.
    Potter WB; O'Riordan KJ; Barnett D; Osting SM; Wagoner M; Burger C; Roopra A
    PLoS One; 2010 Feb; 5(2):e8996. PubMed ID: 20126541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I.
    Brockhoff M; Rion N; Chojnowska K; Wiktorowicz T; Eickhorst C; Erne B; Frank S; Angelini C; Furling D; Rüegg MA; Sinnreich M; Castets P
    J Clin Invest; 2017 Feb; 127(2):549-563. PubMed ID: 28067669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.